Health ❯Healthcare

Chronic Conditions

Diabetes Obesity Diabetes Management Asthma Type 2 Diabetes Hypertension Heart Failure Arthritis Autoimmune Diseases Heart Disease Weight Management Cardiovascular Health Comorbidities Asthma Management Women's Health Renal Disease Cardiovascular Diseases At-Risk Populations Chronic Obstructive Pulmonary Disease Cancer Complications Immunocompromised Patients Parkinson's Disease Influenza GLP-1 Receptor Agonists Patient Care Pain Management HIV Sleep Disorders Lymphedema Diabetes in Pregnancy Kidney Health Urinary Retention Aging Diabetes and Cancer Cardiometabolic Disorders Bronchitis Dental Coverage Lung Disease Epilepsy Hyperphagia Paralysis Fibromyalgia Osteoarthritis Pediatric Health Pediatric Chronic Conditions Risk Factors Diabetes Treatment Diabetic Nephropathy Long COVID Endometriosis COVID-19 Heart Health Obesity Treatment Kidney Disease Osteoporosis Statistics Bone Health Blood Disorders Respiratory Diseases Post-Acute Sequelae Chronic Kidney Disease Back Pain Inflammatory Bowel Disease

CDC Reports Nearly 25,000 ER Visits Linked to Semaglutide in Two Years

New data highlights gastrointestinal complications as the leading cause of adverse events from popular weight-loss drugs like Ozempic and Wegovy.

Semaglutide Shows Promise in Treating Advanced Fatty Liver Disease

Blue Cross Massachusetts Ends GLP-1 Coverage, Point32Health Retains It

PAMI Updates Drug Subsidy Program with New Eligibility Rules and Full Coverage for Critical Treatments

Innovative Injectable Polymer Shows Promise in Post-Heart Attack Tissue Repair

Study Finds Toddlers with Chronic Conditions Face Twice the RSV Hospitalization Risk

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

Mid-Afternoon Inhaler Use Found to Improve Asthma Control in New Study

GLP-1 Drugs Like Ozempic Linked to Lower Dementia Risk in New Studies

UK A&E Departments Failing to Deliver Time-Critical Medications on Time, Report Finds

FDA Approves VYKAT XR, First Therapy for Hyperphagia in Prader-Willi Syndrome

Study Finds 90% of Non-Surgical Back Pain Treatments Lack Effectiveness

Nice Proposes Annual Weight Monitoring for Millions with Long-Term Health Conditions

NHS Approves First Daily Pill for Endometriosis Treatment

UK Drug Shortages Threaten Patient Safety, Pharmacists Warn

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

Study Finds Paxlovid Offers Limited Benefits for Vaccinated Seniors

FDA Approves Ozempic to Reduce Kidney Disease Risks in Type 2 Diabetes Patients

Stem Cell Heart Patches Show Promise in Early Trials

Stammzell-Herzpflaster Shows Promise for Treating Severe Heart Failure

Study Maps Broad Health Impacts of Popular GLP-1 Weight-Loss Drugs

Medicare Expands Drug Price Negotiations to Include Popular Weight-Loss Medications

Norwegian Queen Sonja Recovering After Successful Pacemaker Surgery

GLP-1 Drugs Revolutionize Obesity Treatment While Raising Questions About Risks and Costs

FDA Ends Shortage of Tirzepatide, Restricts Compounded Weight-Loss Drugs

FDA Approves Zepbound as First Drug Treatment for Sleep Apnea

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

NHS to Gradually Roll Out Mounjaro Weight-Loss Drug Over 12 Years

Federal Government Subsidizes First Endometriosis Drug in 30 Years

Navigating Thanksgiving on Weight-Loss Drugs: Expert Advice on Food Choices

UK Doctors Advised to Limit Blue Inhaler Prescriptions Over Environmental and Health Concerns

Diabetes and Obesity Drugs Found to Protect Kidney Health

U.S. Preterm Birth Rates Remain Critically High, New Report Shows

Scotland Faces Health Crisis Linked to Weight-Loss Injections

Nova Scotia Premier Apologizes for Denied Medical Coverage

Germany Faces Medication Shortages Amidst Rising Demand

Canada Enacts Pharmacare Bill for Diabetes and Birth Control Coverage

Whitney Rose's Daughter Hospitalized for Severe Asthma Attack

Wegovy and Ozempic: Celebrity Trends and Health Risks

Semaglutide Shows Promise in Reducing Opioid Overdose Risk, Study Finds

FDA Approves First At-Home Nasal Spray Flu Vaccine

Pfizer's New Drug Shows Promise in Combatting Cancer-Related Weight Loss

Wearable Heart Monitors Improve AFib Detection but Don't Lower Stroke Rates

New Study Confirms Increased Safety in Living Kidney Donations

Semaglutide Shows Significant Cardiovascular Benefits for Heart Failure Patients

European Models Offer Solutions to U.S. Maternal Mortality Crisis

New Study Identifies Distinct Long COVID Symptoms in Children and Adolescents

Routine Lab Tests Ineffective in Diagnosing Long COVID, Study Finds

Researchers Develop 'Smart Insulin' for Improved Diabetes Management

Millions of Americans Using Herbal Supplements Linked to Liver Damage

NHS Approves Groundbreaking Gene-Editing Therapy for Beta Thalassemia

New Osteoporosis Drug Approved for Postmenopausal Women in England

Pharmacists Warn Against Fake Weight-Loss Jabs Amid Ozempic Shortage

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

FDA Issues Warning on Overdoses from Compounded Semaglutide Injections

Roche Accelerates Development of Promising Weight-Loss Pills

First UK Teen Receives Bladder Pacemaker for Rare Condition

Arvind Kejriwal Receives Insulin in Jail Amid Allegations of Medical Neglect